Mechanistic Correlates of Clinical Responses to Omalizumab in the Setting of Oral Immunotherapy for Milk Allergy

BACKGROUND: In our recent clinical trial, the addition of omalizumab to oral immunotherapy (OIT) for milk allergy improved safety but no significant clinical benefit was detected. OBJECTIVE: To investigate mechanisms by which omalizumab modulates immunity in the context of OIT, and to identify basel...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Allergy Clin Immunol
Egile Nagusiak: Frischmeyer-Guerrerio, Pamela A., Masilamani, Madhan, Gu, Wenjuan, Brittain, Erica, Wood, Robert, Kim, Jennifer, Nadeau, Kari, Jarvinen, Kirsi M., Grishin, Alexander, Lindblad, Robert, Sampson, Hugh A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632581/
https://ncbi.nlm.nih.gov/pubmed/28414061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.03.028
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak